By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > Investing > Watches Of Switzerland Shares Soar On Improved Sales, Growth Plan News
Investing

Watches Of Switzerland Shares Soar On Improved Sales, Growth Plan News

News
Last updated: 2023/11/07 at 12:51 PM
By News
Share
4 Min Read
SHARE

Luxury timepiece retailer Watches of Switzerland Group soared on Tuesday as it announced improving sales momentum and divulged details of its new growth strategy.

Contents
Guidance UnchangedGrowth Plan

At 570p per share, the Watches of Switzerland share price was up 9.8% and leading the FTSE 250 higher.

Revenues edged 1% higher during the 13 weeks to 29 October, to £379 million. Stripping out the impact of currency volatility sales were up 5% year on year.

The company said that “demand for luxury watches remains robust and continues to exceed supply,” with sales in the US rising 4% year on year to £165 million. This was up 11% at stable exchange rates.

In the UK and Mainland Europe turnover remained largely unchanged over the period, at £214 million.

For the first half of the financial year, group sales fell fractionally year on year at £761 million, while at constant currencies they were up 2%. Turnover in the US rose 5% (or 11% excluding currency-related effects), while revenues in Britain and the rest of Europe receded 4% on a reported and constant currencies basis.

Guidance Unchanged

Sales of luxury watches — which represent almost nine-tenths of group turnover — were flat during the six months to October, at £670 million, but were up 3% at stable currencies.

Luxury jewellery sales, meanwhile, were down 17% (or 15% at unchanged exchange rates) at £47 million. Watches of Switzerland said that the reversal “[reflected] market trends impacted by overall consumer sentiment and by a repositioning to full price sales in the US.”

The company kept its full-year estimates unchanged following those second-quarter numbers. Revenues are tipped to rise between 8% and 11% at constant currencies, to between £1.65 billion and £1.7 billion.

Chief executive Brian Duffy commented that “I am pleased to report an improved quarter two trading performance, notwithstanding the difficult consumer environment.”

He added that “our proven business model, the strength of our brand partnerships, international scale, bold marketing campaigns and dedication to exceptional client service, continues to drive the business forward.”

Growth Plan

Watches of Switzerland also unveiled a new growth plan through which it hopes to more than double sales during the next five years.

By the end of financial 2028 it hopes to report sales above £3 billion, up from £1.5 billion in the last fiscal period (to April 2023).

Under the plans, the group will continue to upgrade and expand its global showroom network, it said, as well as seek out acquisitions. It plans to spend between £350 million and £500 million in the next five years to pursue this strategy.

Watches of Switzerland also plans to double-down on the sale of luxury branded jewellery and pre-owned watches over the period.

Duffy said that “we are excited by the opportunity available to us in the pre-owned market [and] particularly from the new Rolex Certified Pre-Owned programme, which we expect to deliver 20% of new Rolex in the US and 10% in the UK” by financial 2028.

Watches of Switzerland’s shares slumped in August after Rolex announced plans to enter the retail market by purchasing watch and jewellery seller Bucherer.

Read the full article here

News November 7, 2023 November 7, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

Investing

Gold ETFs Endure Outflows In November But Withdrawals Slow

By News
Investing

Paccar, AWK, Quanta Services, Mastercard, Deere

By News
Investing

Buyback Bonanza Lifts Stocks

By News
Investing

Why Our Top Natural Gas Stock Will Soar In 2024

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?